Dr. Carlotta Petti, PhD, Scientific Director- Nutrigenomics

Dr. Carlotta Petti is a leading voice in the field of nutrigenomics, with a wealth of experience in genetics, nutrition, and public health.

Inquire about Gene by Gene Services

Discover how Gene by Gene can help you and your organisation leverage advanced robotic technology & unlock a personalized end-to-end workflow.

Thank you!

Your submission has been received. Our laboratory will be in touch soon to follow up your enquiry.
An error occurred while submitting the form. Please try again. If the issue persists, please contact our support team.

More Gene by Gene News

Optimizing Health Outcomes with the myDNA Detoxification Report

Optimizing Health Outcomes with the myDNA Detoxification Report

In today's world, we're constantly bombarded with toxins from the air we breathe and the food we eat, to the everyday products we use. Our bodies are working overtime to process and eliminate these harmful substances through a complex process known as detoxification.

Read Article >
Unlocking Personalized Health with the myDNA Methylation Report

Unlocking Personalized Health with the myDNA Methylation Report

The myDNA Methylation Report offers healthcare practitioners a powerful tool to dive into an individual's genetic predisposition to disorders associated with methylation, along with a detailed look at their micronutrient profile.

Read Article >
Methylation: A Deep Dive for Practitioners

Methylation: A Deep Dive for Practitioners

Methylation has emerged as a hot topic in health – but what does it truly entail?

Read Article >
Unlocking the Secrets of Aging: A Practitioner's Guide to the myDNA Longevity Report

Unlocking the Secrets of Aging: A Practitioner's Guide to the myDNA Longevity Report

A Practitioner Longevity Report that is more than just a genetic test; it's a roadmap to personalized health and longevity.

Read Article >
Optimize Cancer Care with Pharmacogenomic Testing

Optimize Cancer Care with Pharmacogenomic Testing

Pharmacogenomics (PGx) is supporting personalized cancer care by helping clinicians to tailor treatment based on individual genetic makeup. This is particularly relevant for tamoxifen, a widely used therapy for breast cancer.

Read Article >